CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this movie before. A company leans hard on a single product, rides momentum while it lasts, then scrambles when ...

From combination surgeries to advanced skin therapies, The Naderi Center outlines how patients nationwide are prioritizing ...

The United States accounts for a significant share of the global remote patient monitoring (RPM) market. The U.S. RPM market ...

Expedited Development Enabled by RMAT and Breakthrough Therapy StatusClinical Trial Initiation in 2026, FDA Approval Target ...

Weekly Oral Helicase-Primase Inhibitor Programs' Early Data Potentially Supportive of First New Treatment for Recurrent ...

Digital patient monitoring systems (DPMS) market refer to a broad spectrum of technologies designed to continuously monitor ...

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within the timelines required by law, resulting in years-long delay of medical cannabis ...

Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug ...

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...

Ondine and Mid Yorkshire Teaching NHS Trust shortlisted for Excellence in Healthcare Partnership Award for Reducing Surgical Site Infections with Nasal Photodisinfection Second national award ...

This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally exposed the truth: the DEA marijuana obstruction was never about public safety. It ...

The global AI in cardiology market size is expected to reach USD 14.83 billion by 2033, registering a CAGR of 31.17% from ...